Driving innovation through the new Liverpool Accelerate Laboratory
The new Liverpool Accelerate Laboratory brings together high-containment research, robotics, artificial intelligence, and human organoid technology in a facility designed to accelerate infectious disease research while reducing researchers’ direct interaction with hazardous materials.
Our Senior Business Development Manager, Dr Mike Egan, who has been leading the delivery and specification of the new facility, spoke to Lab Design News about the lab and how it is integrating robotics with high containment research to accelerate the discovery of next generation drugs and vaccines.
